MIRA Pharmaceuticals (MIRA) Competitors $1.90 -0.29 (-13.24%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MIRA vs. CKPT, ACRS, ANVS, RANI, TLSA, MCRB, PDSB, ME, INMB, and HOWLShould you be buying MIRA Pharmaceuticals stock or one of its competitors? The main competitors of MIRA Pharmaceuticals include Checkpoint Therapeutics (CKPT), Aclaris Therapeutics (ACRS), Annovis Bio (ANVS), Rani Therapeutics (RANI), Tiziana Life Sciences (TLSA), Seres Therapeutics (MCRB), PDS Biotechnology (PDSB), 23andMe (ME), INmune Bio (INMB), and Werewolf Therapeutics (HOWL). These companies are all part of the "pharmaceutical products" industry. MIRA Pharmaceuticals vs. Checkpoint Therapeutics Aclaris Therapeutics Annovis Bio Rani Therapeutics Tiziana Life Sciences Seres Therapeutics PDS Biotechnology 23andMe INmune Bio Werewolf Therapeutics Checkpoint Therapeutics (NASDAQ:CKPT) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability, community ranking and analyst recommendations. Do analysts prefer CKPT or MIRA? Checkpoint Therapeutics presently has a consensus target price of $12.00, suggesting a potential upside of 241.88%. MIRA Pharmaceuticals has a consensus target price of $14.00, suggesting a potential upside of 636.84%. Given MIRA Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe MIRA Pharmaceuticals is more favorable than Checkpoint Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Checkpoint Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the MarketBeat Community believe in CKPT or MIRA? Checkpoint Therapeutics received 172 more outperform votes than MIRA Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave MIRA Pharmaceuticals an outperform vote while only 66.79% of users gave Checkpoint Therapeutics an outperform vote. CompanyUnderperformOutperformCheckpoint TherapeuticsOutperform Votes17566.79% Underperform Votes8733.21% MIRA PharmaceuticalsOutperform Votes3100.00% Underperform VotesNo Votes Which has stronger valuation and earnings, CKPT or MIRA? MIRA Pharmaceuticals has lower revenue, but higher earnings than Checkpoint Therapeutics. MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Checkpoint Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheckpoint Therapeutics$78K2,025.81-$51.85M-$1.90-1.85MIRA PharmaceuticalsN/AN/A-$11.98M-$0.68-2.79 Does the media favor CKPT or MIRA? In the previous week, MIRA Pharmaceuticals had 1 more articles in the media than Checkpoint Therapeutics. MarketBeat recorded 3 mentions for MIRA Pharmaceuticals and 2 mentions for Checkpoint Therapeutics. MIRA Pharmaceuticals' average media sentiment score of 0.38 beat Checkpoint Therapeutics' score of -0.11 indicating that MIRA Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Checkpoint Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MIRA Pharmaceuticals 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of CKPT or MIRA? 22.0% of Checkpoint Therapeutics shares are held by institutional investors. Comparatively, 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. 2.1% of Checkpoint Therapeutics shares are held by insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, CKPT or MIRA? Checkpoint Therapeutics has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 4.2, meaning that its stock price is 320% more volatile than the S&P 500. Is CKPT or MIRA more profitable? Checkpoint Therapeutics' return on equity of 0.00% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Checkpoint TherapeuticsN/A N/A -672.98% MIRA Pharmaceuticals N/A -286.24%-246.14% SummaryMIRA Pharmaceuticals beats Checkpoint Therapeutics on 12 of the 16 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRA vs. The Competition Export to ExcelMetricMIRA PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.08M$7.42B$5.50B$8.53BDividend YieldN/A7.96%5.13%4.14%P/E Ratio-2.7910.05116.1015.23Price / SalesN/A400.761,496.2597.74Price / CashN/A47.3939.7434.10Price / Book6.335.594.775.07Net Income-$11.98M$153.56M$119.06M$225.46M7 Day Performance47.29%0.13%0.80%0.37%1 Month Performance58.33%15.23%5.65%3.57%1 Year Performance23.38%41.14%36.75%29.43% MIRA Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRAMIRA Pharmaceuticals3.2265 of 5 stars$1.90-13.2%$14.00+636.8%+25.8%$28.08MN/A-2.792CKPTCheckpoint Therapeutics3.4263 of 5 stars$3.62-5.7%$12.00+231.5%+90.8%$129.18M$78,000.00-1.9110Short Interest ↑High Trading VolumeACRSAclaris Therapeutics3.3165 of 5 stars$1.80+5.3%$9.00+400.0%-58.9%$128.28M$32.02M-2.2086Upcoming EarningsPositive NewsANVSAnnovis Bio2.2307 of 5 stars$9.56-2.1%$32.17+236.6%+44.9%$124.73MN/A-1.873Short Interest ↑RANIRani Therapeutics3.1035 of 5 stars$2.32-0.9%$11.71+404.9%+20.9%$123.90M$2.72M-1.97110Gap UpTLSATiziana Life Sciences1.451 of 5 stars$1.18+15.7%N/A+44.6%$121.64MN/A0.008News CoverageGap DownHigh Trading VolumeMCRBSeres Therapeutics3.8567 of 5 stars$0.78+1.3%$5.08+549.4%-42.9%$118.55M$374,000.00-0.66233Upcoming EarningsGap DownPDSBPDS Biotechnology0.8513 of 5 stars$3.22-0.3%$14.25+343.2%-23.4%$118.38MN/A-2.6420Analyst UpgradeME23andMe1.9256 of 5 stars$4.81-2.6%$9.40+95.4%-71.6%$117.91M$199.19M-0.18770INMBINmune Bio2.5574 of 5 stars$5.95-5.6%$20.00+236.1%-14.6%$117.58M$85,000.00-2.8910Short Interest ↑News CoverageGap UpHOWLWerewolf Therapeutics3.8768 of 5 stars$2.69-1.1%$12.00+346.1%+8.8%$117.56M$9.28M-1.9540News Coverage Related Companies and Tools Related Companies Checkpoint Therapeutics Competitors Aclaris Therapeutics Competitors Annovis Bio Competitors Rani Therapeutics Competitors Tiziana Life Sciences Competitors Seres Therapeutics Competitors PDS Biotechnology Competitors 23andMe Competitors INmune Bio Competitors Werewolf Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MIRA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
